Ipamorelin vs CJC-1295: Which Should You Use?
Ipamorelin and CJC-1295 are two of the most popular growth hormone peptides available - and they are almost always discussed together. Here is why they work better as a stack than either does alone, and how to choose the right approach for your goals.
The key difference
Ipamorelin is a GHRP (growth hormone-releasing peptide) that works on ghrelin receptors. CJC-1295 is a GHRH analog that works on GHRH receptors. Because they target completely different receptor systems, stacking them produces a synergistic effect - significantly more growth hormone release than either compound alone.
Why they are almost always used together: The Ipamorelin plus CJC-1295 stack is one of the most popular GH optimization protocols available. Using both simultaneously hits two separate pathways that both lead to GH release - the combined pulse is dramatically larger than either peptide produces individually.
Ipamorelin: clean and selective
Ipamorelin is a third-generation GHRP known for its selectivity - it produces a clean GH pulse without significantly raising cortisol, prolactin, or appetite. This makes it the most side-effect-friendly option in the GHRP category and ideal for everyday use in ongoing protocols.
Its effects are relatively short-lived compared to CJC-1295 - the GH pulse it triggers lasts 1 - 3 hours. This makes timing important: most users inject Ipamorelin 30 minutes before bed to align with the body's natural nighttime GH release. Read our full Ipamorelin guide and Ipamorelin dosage guide.
CJC-1295: sustained elevation
CJC-1295 is a modified GHRH analog that extends the half-life of natural GHRH dramatically. Where natural GHRH lasts only minutes in the bloodstream, CJC-1295 with DAC (Drug Affinity Complex) lasts up to two weeks. This creates a sustained elevation in GH and IGF-1 levels rather than sharp pulses.
CJC-1295 without DAC (also called Mod GRF 1-29) has a shorter half-life of about 30 minutes and produces a more pulsatile pattern similar to natural GHRH. Most users prefer CJC-1295 without DAC for its more physiological release pattern and greater control over dosing.
Side by side comparison
| Feature | Ipamorelin | CJC-1295 |
|---|---|---|
| Type | GHRP (ghrelin receptor) | GHRH analog |
| Half-life | 2 hours | 30 min (no DAC) / 2 weeks (with DAC) |
| GH release pattern | Sharp pulse | Sustained elevation |
| Raises cortisol? | No | No |
| Raises appetite? | No | No |
| Typical dose | 200 - 300 mcg | 100 - 200 mcg (no DAC) |
| Dosing frequency | Daily | Daily (no DAC) / Weekly (with DAC) |
| Best used | Alone or stacked | Almost always stacked with GHRP |
Why the Ipamorelin + CJC-1295 stack works
The reason this stack is so popular comes down to basic receptor pharmacology. Your pituitary has two types of receptors that trigger GH release: GHRH receptors (targeted by CJC-1295) and ghrelin receptors (targeted by Ipamorelin). When both receptor systems are activated simultaneously, the GH release is significantly amplified beyond what either achieves alone.
A typical stack protocol uses 100 - 200 mcg of CJC-1295 (without DAC) plus 200 - 300 mcg of Ipamorelin, injected together subcutaneously 30 minutes before bed. This combination produces a large, natural-feeling GH pulse that aligns with the body's nighttime release pattern.
Compared to Sermorelin plus Ipamorelin (the other popular GHRH + GHRP stack), CJC-1295 plus Ipamorelin tends to produce a larger GH pulse due to CJC-1295's modified structure. The Sermorelin plus Ipamorelin stack is considered slightly more natural and conservative. Both are valid approaches depending on your goals.
Find a clinic near you
Ready to start peptide therapy? Tides connects you with vetted clinics across the US that can prescribe and supervise your protocol:
Don't see your city? Join the waitlist and we will notify you when a vetted clinic is available near you.